AngioDynamics (NASDAQ:ANGO – Get Rating) had its price target lowered by equities researchers at Raymond James from $22.00 to $14.00 in a research report issued to clients and investors on Monday, Benzinga reports. The brokerage currently has a “strong-buy” rating on the medical instruments supplier’s stock. Raymond James’ price objective would indicate a potential upside […]